Results 141 to 150 of about 12,357,672 (189)

Correction to "Schisandrin B Suppresses Colon Cancer Growth by Inducing Cell Cycle Arrest and Apoptosis: Molecular Mechanism and Therapeutic Potential". [PDF]

ACS Pharmacol Transl Sci
Co VA, El-Nezami H, Liu Y, Twum B, Dey P, Cox PA, Joseph S, Agbodjan-Dossou R, Sabzichi M, Draheim R, Wan MLY.   +10 more
europepmc   +1 more source

Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through AKT-mTOR pathway. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Yang J, Zhou D, Hu J, Yang DH, Cai Y, Lu Q.   +5 more
europepmc   +1 more source

Schisandrin B alleviates testicular inflammation and Sertoli cell apoptosis via AR-JNK pathway. [PDF]

Sci Rep
Zhang BY, Yang R, Zhu WQ, Zhu CL, Chen LX, Zhao YS, Zhang Y, Wang YQ, Jiang DZ, Tang B, Zhang XM.   +10 more
europepmc   +1 more source

Schisandrin B Suppresses Colon Cancer Growth by Inducing Cell Cycle Arrest and Apoptosis: Molecular Mechanism and Therapeutic Potential. [PDF]

ACS Pharmacol Transl Sci
Co VA, El-Nezami H, Liu Y, Twum B, Dey P, Cox PA, Joseph S, Agbodjan-Dossou R, Sabzichi M, Draheim R, Wan MLY.   +10 more
europepmc   +1 more source

The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production. [PDF]

Biomolecules
Chang CM, Liang TR, Lam HYP.
europepmc   +1 more source

[Retracted] Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways. [PDF]

Oncol Rep
Li S, Wang H, Ma R, Wang L.
europepmc   +1 more source

Schisandrin B, a dual positive allosteric modulator of GABA_A and glycine receptors, alleviates seizures in multiple mouse models. [PDF]

Acta Pharmacol Sin
Wu J, Zhao M, Jin YC, Li M, Yu KX, Yu HB.   +5 more
europepmc   +1 more source

A novel experimental model of acute hypertriglyceridemia induced by schisandrin B

European Journal of Pharmacology, 2006
Mice were intragastrically treated with single doses (0.05-0.8 g/kg) of schisandrin B (a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis). Twenty-four hours after schisandrin B administration, the serum triglyceride level was increased by 10-235% in a dose-dependent manner.
Si-Yuan Pan, Yifan Han, Kam-Ming Ko
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Schisandrin B—A novel inhibitor of P-glycoprotein

Biochemical and Biophysical Research Communications, 2005
P-glycoprotein-mediated drug efflux is one of the major causes of the cancer multidrug resistance (MDR). Inhibition of P-glycoprotein could reverse cancer MDR. Here, we show that schisandrin B, a naturally occurring compound from Schisandra chinensis (Turcz.) Baill, bears strong potency to inhibit P-glycoprotein.
Qinghua Lu
exaly   +3 more sources